S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Laser breakthrough could send stock soaring 2,467% (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Laser breakthrough could send stock soaring 2,467% (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Laser breakthrough could send stock soaring 2,467% (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Laser breakthrough could send stock soaring 2,467% (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
66,000% upside on tiny biotech? (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
NASDAQ:TRVN

Trevena (TRVN) Earnings Date, Estimates & Call Transcripts

$0.66
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.65
▼
$0.68
50-Day Range
$0.66
▼
$1.02
52-Week Range
$0.54
▼
$5.13
Volume
61,673 shs
Average Volume
1.71 million shs
Market Capitalization
$9.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 8Estimated
Actual EPS
(Aug. 14)
-$0.69 Missed By -$0.24
Consensus EPS
(Aug. 14)
-$0.45
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TRVN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRVN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Trevena Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($1.69)($1.50)($1.60)
Q2 20232($1.50)($0.96)($1.23)
Q3 20232($1.50)($0.92)($1.21)
Q4 20232($1.25)($0.89)($1.07)
FY 20238($5.94)($4.27)($5.11)

TRVN Earnings Date and Information

Trevena last released its quarterly earnings results on August 14th, 2023. The biopharmaceutical company reported ($0.69) EPS for the quarter, missing analysts' consensus estimates of ($0.45) by $0.24. The business earned $3.02 million during the quarter, compared to analysts' expectations of $0.70 million. Trevena has generated ($4.48) earnings per share over the last year (($4.48) diluted earnings per share). Earnings for Trevena are expected to grow in the coming year, from ($2.10) to ($1.09) per share. Trevena has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off prior year's report dates.

Trevena Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2023
Estimated)		------- 
8/14/2023Q2 2023($0.45)($0.69)($0.24)($0.69)$0.70 million$3.02 million
5/15/2023Q1 2023($0.85)($0.81)+$0.04($0.81)$0.60 million$0.01 million    
3/30/2023Q4 2022-($0.73)($0.73)($0.73)--
11/9/2022Q3 2022($56.25)($56.25)-($2.25)$0.43 million($0.44) million
8/11/2022Q2 2022($2.75)($2.25)+$0.50($0.09)--
5/11/2022Q1 2022($2.25)($2.50)($0.25)($0.10)$0.65 million$0.02 million    
3/31/2022Q4 2021($2.25)($2.00)+$0.25($0.08)--    
11/15/2021Q3 2021($2.25)($2.00)+$0.25($0.08)$1.16 million$0.18 million    
8/12/2021Q2 2021($2.00)($2.25)($0.25)($0.09)$1.26 million$0.18 million    
5/6/2021Q1 2021($2.00)($1.50)+$0.50($0.06)$0.55 million$0.21 million  
3/8/2021Q4 2020($1.50)($2.00)($0.50)($0.08)-$0.07 million  
11/2/2020Q3 2020($1.00)($1.00)-($0.04)$3.00 million$3.00 million












Trevena Earnings - Frequently Asked Questions

When is Trevena's earnings date?

Trevena has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off last year's report dates. Learn more on TRVN's earnings history.

Did Trevena beat their earnings estimates last quarter?

In the previous quarter, Trevena (NASDAQ:TRVN) missed the analysts' consensus estimate of ($0.45) by $0.24 with a reported earnings per share (EPS) of ($0.69). Learn more on analysts' earnings estimate vs. TRVN's actual earnings.

How much revenue does Trevena generate each year?

Trevena (NASDAQ:TRVN) has a recorded annual revenue of $570,000.00.

How much profit does Trevena generate each year?

Trevena (NASDAQ:TRVN) has a recorded net income of -$53.67 million. TRVN has generated -$4.48 earnings per share over the last four quarters.

What is Trevena's EPS forecast for next year?

Trevena's earnings are expected to grow from ($2.10) per share to ($1.09) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:TRVN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -